You can't fault Merck-Serono's sense of timing. The very day after the European Union called for a European focus on rare diseases, a cornerstone ceremony marked the expansion of the Merck Serono Biotech Center at its Corsier-sur-Vevey site in Switzerland.
Our prediction earlier this month of an impending battle in Brussels over parallel importing has proved chillingly accurate, and deserves a follow-up. Contrary to all expectations - and there were many! - the EU did not propose tighter wholesaling rules on the scheduled date of October 21.
Daggers are drawn in Brussels as warring parties within the pharmaceutical industry prepare for the latest phase in the long battle over parallel importing.
Reflector looks ahead to Leem's extended dialogue with the public on the place of medicines in society, taking place next month.
Reflector outlines what you can expect if you have a meeting with EMEA lined up in the near future.
Make the most of your summer holiday because regulatory matters will be hotting up in the autumn.
Reflector reviews the EFPIA's new code of practice for dealing with patient organisations.
The EU is gearing up to address the topic of patient communication. But we'd better not hold our collective breath, says Reflector.
Reflector ponders whether the new EC report on DTC is a useful policy making or just another exercise in stating "the bleeding obvious."
